Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romero

Showing results (271-280 of 53,427) with videos related to

Pageof 5,343
Sort By:
Nature Reviews. Clinical Oncology|November 28, 2019
Two new agents target KRAS G12CDiana Romero
Nature Reviews. Clinical Oncology|February 16, 2020
NELSON updatedDiana Romero
Nature Reviews. Clinical Oncology|January 20, 2019
FOLFIRINOX goes adjuvantDiana Romero
American Journal of Obstetrics and Gynecology|December 29, 2018
A tribute to Ingrid Nygaard, MD, MS, Editor-in-Chief for Gynecology, 2014-2018Roberto Romero
American Journal of Obstetrics and Gynecology|December 29, 2018
Catherine S. Bradley, MD, MSCE, AJOG's new Editor-in-Chief for GynecologyRoberto Romero
Nature Reviews. Clinical Oncology|November 30, 2018
Adjuvant TKIs - a long-term matterDiana Romero
Psychiatrie, Neurologie, Und Medizinische Psychologie|December 1, 1980
[An example of rehabilitation of speech by mediation-techniques in aphasia]B Romero
Boletin De La Oficina Sanitaria Panamericana. Pan American Sanitary Bureau|September 1, 1982
[Policies and strategies for leprosy control programs]A Romero
Nature Reviews. Clinical Oncology|January 28, 2026
Anbenitamab is a new second-line option in G/GEJ adenocarcinomaDiana Romero
Nature Reviews. Clinical Oncology|February 7, 2025
Cadonilimab is efficacious in HER2-negative advanced-stage G/GEJ adenocarcinomasDiana Romero
Pageof 5,343

Showing results (271-280 of 53,427) with videos related to

Sort By:
Pageof 5,343
Nature Reviews. Clinical Oncology|November 28, 2019
Two new agents target KRAS G12CDiana Romero
Nature Reviews. Clinical Oncology|February 16, 2020
NELSON updatedDiana Romero
Nature Reviews. Clinical Oncology|January 20, 2019
FOLFIRINOX goes adjuvantDiana Romero
American Journal of Obstetrics and Gynecology|December 29, 2018
A tribute to Ingrid Nygaard, MD, MS, Editor-in-Chief for Gynecology, 2014-2018Roberto Romero
American Journal of Obstetrics and Gynecology|December 29, 2018
Catherine S. Bradley, MD, MSCE, AJOG's new Editor-in-Chief for GynecologyRoberto Romero
Nature Reviews. Clinical Oncology|November 30, 2018
Adjuvant TKIs - a long-term matterDiana Romero
Psychiatrie, Neurologie, Und Medizinische Psychologie|December 1, 1980
[An example of rehabilitation of speech by mediation-techniques in aphasia]B Romero
Boletin De La Oficina Sanitaria Panamericana. Pan American Sanitary Bureau|September 1, 1982
[Policies and strategies for leprosy control programs]A Romero
Nature Reviews. Clinical Oncology|January 28, 2026
Anbenitamab is a new second-line option in G/GEJ adenocarcinomaDiana Romero
Nature Reviews. Clinical Oncology|February 7, 2025
Cadonilimab is efficacious in HER2-negative advanced-stage G/GEJ adenocarcinomasDiana Romero
Pageof 5,343